<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.themoneyblogs.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>GERN</title>
 <link>http://www.themoneyblogs.com/gern</link>
 <description>The taxonomy view with a depth of 0.</description>
 <language>en</language>
<item>
 <title>GE Taking Decisive Step Into Stem Cells (GE, GERN, STEM, ASTM)</title>
 <link>http://www.themoneyblogs.com/trading/247wallst/ge-taking-decisive-step-into-stem-cells-ge-gern-stem-astm.html</link>
 <description>&lt;!--paging_filter--&gt;General Electric Company (NYSE: GE) is taking a bold and controversial new step into the field of embryonic stem cell research.&amp;nbsp; The company has signed an exclusive license and alliance pact with &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.themoneyblogs.com/trading/247wallst/ge-taking-decisive-step-into-stem-cells-ge-gern-stem-astm.html&quot;&gt;&amp;nbsp;read&amp;nbsp;more&amp;nbsp;&amp;raquo;&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.themoneyblogs.com/trading/247wallst/ge-taking-decisive-step-into-stem-cells-ge-gern-stem-astm.html#comments</comments>
 <category domain="http://www.themoneyblogs.com/trading/247wallst">247Wallst</category>
 <category domain="http://www.themoneyblogs.com/astm">ASTM</category>
 <category domain="http://www.themoneyblogs.com/biomedicin">biomedicin</category>
 <category domain="http://www.themoneyblogs.com/ge">GE</category>
 <category domain="http://www.themoneyblogs.com/general-electric">General Electric</category>
 <category domain="http://www.themoneyblogs.com/gern">GERN</category>
 <category domain="http://www.themoneyblogs.com/stem">STEM</category>
 <category domain="http://www.themoneyblogs.com/stem-cell-research">stem cell research</category>
 <pubDate>Tue, 30 Jun 2009 12:32:10 -0400</pubDate>
 <dc:creator>247Wallst</dc:creator>
 <guid isPermaLink="false">25791 at http://www.themoneyblogs.com</guid>
</item>
</channel>
</rss>
